nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of international breast cancer guidelines – Do the national guidelines differ in treatment recommendations?
|
Wolters, R. |
|
2012 |
48 |
1 |
p. 1-11 11 p. |
artikel |
2 |
A phase II study of 18F-fluorodeoxyglucose PET–CT in non-small cell lung cancer patients receiving erlotinib (Tarceva®); objective and symptomatic responses at 6 and 12weeks
|
O’Brien, M.E.R. |
|
2012 |
48 |
1 |
p. 68-74 7 p. |
artikel |
3 |
Clinical outcome in children and adolescents with Hodgkin lymphoma after treatment with chemotherapy alone – The results of the United Kingdom HD3 national cohort trial
|
Shankar, Ananth |
|
2012 |
48 |
1 |
p. 108-113 6 p. |
artikel |
4 |
Colorectal cancer survival in socioeconomic groups in England: Variation is mainly in the short term after diagnosis
|
Møller, Henrik |
|
2012 |
48 |
1 |
p. 46-53 8 p. |
artikel |
5 |
CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells
|
Monnier, Justin |
|
2012 |
48 |
1 |
p. 138-148 11 p. |
artikel |
6 |
Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009–2010: The AnemOnHe study
|
Spielmann, Marc |
|
2012 |
48 |
1 |
p. 101-107 7 p. |
artikel |
7 |
Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer
|
Berglund, Anders |
|
2012 |
48 |
1 |
p. 75-84 10 p. |
artikel |
8 |
Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer
|
Fedele, P. |
|
2012 |
48 |
1 |
p. 24-29 6 p. |
artikel |
9 |
Establishing an EGFR mutation screening service for non-small cell lung cancer – Sample quality criteria and candidate histological predictors
|
Leary, Alexandra F. |
|
2012 |
48 |
1 |
p. 61-67 7 p. |
artikel |
10 |
Human adipose tissue-derived mesenchymal stem cells: Characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas
|
Choi, Seung Ah |
|
2012 |
48 |
1 |
p. 129-137 9 p. |
artikel |
11 |
Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation
|
Karn, Thomas |
|
2012 |
48 |
1 |
p. 12-23 12 p. |
artikel |
12 |
Polymorphisms in MUC1, MUC2, MUC5B and MUC6 genes are not associated with the risk of chronic atrophic gastritis
|
Frank, Bernd |
|
2012 |
48 |
1 |
p. 114-120 7 p. |
artikel |
13 |
Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: A phase II trial
|
Kennecke, Hagen |
|
2012 |
48 |
1 |
p. 37-45 9 p. |
artikel |
14 |
Prevalence of BRAF V600E mutation in Chinese melanoma patients: Large scale analysis of BRAF and NRAS mutations in a 432-case cohort
|
Si, Lu |
|
2012 |
48 |
1 |
p. 94-100 7 p. |
artikel |
15 |
Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
|
Fizazi, K. |
|
2012 |
48 |
1 |
p. 85-93 9 p. |
artikel |
16 |
Risk of coronary heart disease in patients with cancer: A nationwide follow-up study from Sweden
|
Zöller, Bengt |
|
2012 |
48 |
1 |
p. 121-128 8 p. |
artikel |
17 |
Scoring to predict the possibility of upgrades to malignancy in atypical ductal hyperplasia diagnosed by an 11-gauge vacuum-assisted biopsy device: An external validation study
|
Bendifallah, S. |
|
2012 |
48 |
1 |
p. 30-36 7 p. |
artikel |
18 |
The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion
|
Luk, Sze Ki |
|
2012 |
48 |
1 |
p. 149-157 9 p. |
artikel |
19 |
Variation in surgical resection for lung cancer in relation to survival: Population-based study in England 2004–2006
|
Riaz, Sharma P. |
|
2012 |
48 |
1 |
p. 54-60 7 p. |
artikel |